Tag: Drug Safety
FDA: Higher Risk for Death Found With Venclexta in Multiple Myeloma
Enrollment suspended for trials investigating Venclexta for treatment of multiple myeloma
Bill to Fight U.S. Opioid Crisis Signed Into Law
Legislation expands treatment options, removes ban on Medicaid reimbursement at certain facilities
Testosterone Prescribing Down Since 2013
Decline coincided with reports linking testosterone to adverse cardiovascular events
International Group Develops Best Practices for Drug Packaging
Global regulators recommend adoption of ready-to-use/administer syringes and premixed IV solutions
Prescription-Strength Steroids Sold Without Prescription
Case report highlights Funbact-A, available online, which contains prescription-strength betamethasone
Postmarket Safety Events for 32 Percent of Novel Therapeutics
Thirty-two percent of 222 FDA approved novel therapeutics from 2001 to 2010 were affected
Variation in Risk of Adverse Outcomes With Metamizole
Relative risk estimates vary from 1.5 to 40.2 for agranulocytosis, from 1.5 to 2.7 for upper GI bleed
